Preliminary classification criteria for the cryoglobulinaemic vasculitis

Background To develop preliminary classifi cation criteria for the cryoglobulinaemic syndrome or cryoglobulinaemic vasculitis (CV). Methods Study part I developed a questionnaire for CV to be included in the formal, second part (study part II). Positivity of serum cryoglobulins was defi ned by experts as an essential condition for CV classifi cation. In study part II, a core set of classifi cation items (questionnaire, clinical and laboratory items, as agreed) was tested in three groups of patients and controls—that is, group A (new patients with the CV), group B (controls with serum cryoglobulins but lacking CV) and group C (controls without serum cryoglobulins but with features which can be observed in CV). Results In study part I (188 cases, 284 controls), a positive response to at least two of three selected questions showed a sensitivity of 81.9% and a specifi city of 83.5% for CV. This questionnaire was employed and validated in study part II, which included 272 patients in group A and 228 controls in group B. The fi nal classifi cation criteria for CV, by pooling data from group A and group B, required the positivity of questionnaire plus clinical, questionnaire plus laboratory, or clinical plus laboratory items, or all the three, providing a sensitivity of 88.5% and a specifi city of 93.6% for CV. By comparing data in group A versus group C (425 controls), the same classifi cation criteria showed a sensitivity 88.5% and a specifi city 97.0% for CV. Conclusion Classifi cation criteria for CV were developed, and now need validation.

[1]  G. Pasero,et al.  Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. , 2010, Arthritis and rheumatism.

[2]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. , 2010, Arthritis and rheumatism.

[3]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[4]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. , 2010, Arthritis and rheumatism.

[5]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. , 2010, Arthritis and rheumatism.

[6]  D. Landau,et al.  Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis. , 2008, Arthritis and rheumatism.

[7]  H. Raspe,et al.  EULAR recommendations for the management of primary small and medium vessel vasculitis , 2008, Annals of the Rheumatic Diseases.

[8]  J. Singh,et al.  Classification criteria in rheumatic diseases: a review of methodologic properties. , 2007, Arthritis and rheumatism.

[9]  M. Dougados,et al.  Classification criteria for rheumatic diseases: why and how? , 2007, Arthritis and rheumatism.

[10]  J. Piette,et al.  Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia. , 2005, Journal of hepatology.

[11]  P. Lamprecht [The cryoglobulinemic syndrome--report from the workshop on classification and on the 10th conference of the Italian Society for the treatment of Cryoglobulinemia, Modena, 29 Sept., 2003]. , 2004, Zeitschrift für Rheumatologie (Print).

[12]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[13]  Y. Shoenfeld,et al.  Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. , 1996, Annals of the rheumatic diseases.

[14]  M. Pietrogrande,et al.  Classification of the cryoglobulinemic syndrome. , 1995, Clinical and experimental rheumatology.

[15]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[16]  R. Chung,et al.  A role for hepatitis C virus infection in type II cryoglobulinemia. , 1992, The New England journal of medicine.

[17]  B. Frangione,et al.  Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. , 1991, Seminars in hematology.

[18]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[19]  J. Clauvel,et al.  Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.

[20]  M. Meltzer,et al.  Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. , 1966, The American journal of medicine.

[21]  A. Gibofsky American College of Rheumatology. , 2002, Journal of the Medical Association of Georgia.

[22]  R. Jonsson,et al.  EuropeanStudy Group on Classification Criteria for Sjögren's Syndrome. Classificationcriteria for Sjögren's syndrome: a revised version of the European criteriaproposed by the American-European Consensus Group , 2002 .

[23]  S. Pileri,et al.  Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. , 2000, Arthritis and rheumatism.